InDevR to Develop Influenza Assay with CDC | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life sciences assay developer InDevR is collaborating with researchers at the US Centers for Disease Control and Prevention's Influenza Division to develop a microarray assay for use in influenza virus screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Nature News explores the president's "science legacy."

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.